Items Tagged ‘Hematology’

December 13, 2013

Mayo Clinic in the News Weekly Highlights

By Karl W Oestreich Karl W Oestreich

    December 13, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]

View full entry

Tags: ABC News, AIDS, Altru Health System, American Society of Hematology, Anastrozole, AP, Arimidex, ASH, Asperger's, Associated Press, Austin Public Schools, BBC


July 12, 2013

Mayo Clinic in the News Weekly Highlights

By Karl W Oestreich Karl W Oestreich

July 12 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations Philadelphia Enquirer […]

View full entry

Tags: ABC News, ABC News Nightline, ABCnews.com, acid reflux, alzheimer's disease, and Blood Institute, antibiotics, antidepressants, Arizona Republic, Australian News, bio-plotter, biomedical corridor


May 3, 2013

Mayo Clinic in the News Weekly Highlights

By Karl W Oestreich Karl W Oestreich

    May 3, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]

View full entry

Tags: alzheimer's disease, Anesthesiology, anxiety, Arizona, Arizona Horizon, Arizona Republic, Arizona State University, ASU, Austin Daily Herald, Big Group, Breast Cancer, Breast Cancer Interest Group


September 10, 2009

Cytopia’s CYT387 Receives FDA Clearance to Start US Clinical Trials

By Kelley Luckstein Kelley Luckstein

Cytopia Limited’s (ASX: CYT) Investigational New Drug Application (IND) for CYT387 has passed US Food and Drug Administration (FDA) review. CYT387 is a small-molecule oral JAK1/JAK2 kinase inhibitor designed to treat various hematological disorders…   Preparations for the company’s initial Phase I/II trial  of CYT387 in patients with myelofibrosis are currently being finalized. Myelofibrosis is […]

View full entry

Tags: clinical trials, Hematology


August 26, 2009

Mayo Clinic Proceedings: Common blood disorder may not be linked to as many serious diseases

By Kelley Luckstein Kelley Luckstein

A symptomless blood disorder, monoclonal gammopathy of undetermined significance, known as MGUS, is not linked to as many serious diseases as previously thought. This finding may save patients from undergoing unnecessary workup and treatment according to a study published in the August 2009 issue of Mayo Clinic Proceedings.   First Science, 8/25/09   Additional coverage: […]

View full entry

Tags: Hematology, Mayo Clinic Proceedings


Contact Us · Privacy Policy